Estrace (Estradiol): Comprehensive Patient Information for Australia
Basic Product Information
| International Nonproprietary Name (INN) | Estradiol |
|---|---|
| Australia Brand Names | Estrace, Estrofem, Estalis, Progynova, Zumenon, Sandrena Gel, Oestraderm, Climara |
| ATC Code | G03CA03 |
| Available Forms & Strengths | Tablets (0.5 mg, 1 mg, 2 mg), transdermal patches (25–100 micrograms/24 hr), topical gel (0.6 mg/g), vaginal tablets (10 micrograms), topical cream (0.01%, 0.1%), injectable (various strengths) |
| Manufacturers | Pfizer, Novo Nordisk, Bayer, Mylan, Besins Healthcare, Aspen Pharma, Viatris |
| Prescription Status in Australia | Prescription Only Medicine (Schedule 4, S4) |
Mechanism of Action
For Everyone: Estrace contains estradiol, a form of oestrogen—a natural female hormone that helps maintain the health of the reproductive system and other body systems. It replaces or supplements the body’s own oestrogen, especially helpful when levels fall during menopause or other medical conditions.
For Specialists:- Estradiol binds to and activates oestrogen receptors (ER-α and ER-β) in target tissues (endometrium, bone, vagina, CNS, etc).
- This leads to modulation of gene transcription and protein synthesis affecting cell growth, differentiation, bone metabolism, and lipid profile.
- Estradiol exerts negative feedback on the hypothalamic-pituitary axis, reducing LH/FSH, stabilising hormonal cycles.
Pharmacokinetics
- Absorption: Oral: Rapid and well absorbed, but significant first-pass hepatic metabolism. Transdermal and vaginal forms bypass the liver, offering more stable levels.
- Distribution: Widely distributed, protein-bound (albumin, SHBG).
- Metabolism: Mainly hepatic (CYP3A4), forming estrone, estriol, and conjugates.
- Elimination: Metabolites excreted primarily via urine, some in bile/stool.
- Duration of Action: Varies by route; oral: 12–24 h, patch: 3–4 days, gel: daily.
Use in Everyday Life & Best Practices
Estrace is most commonly prescribed in Australia for symptoms of menopause (hot flushes, night sweats, vaginal dryness), for certain gynaecological conditions, and to prevent osteoporosis when other therapies are unsuitable. It may also be used for hormone replacement in individuals with low oestrogen due to hypogonadism or surgical removal of the ovaries.
- For menopausal symptoms, the starting dose is usually the lowest effective one, e.g., 0.5–1 mg oral, or the lowest strength patch.
- Vaginal tablets/creams are used for local symptoms (vaginal atrophy/dryness), typically inserted before bed.
- Use the prescribed form (tablet, gel, patch, cream) as directed. If you miss a dose, take it as soon as possible unless it is nearly time for your next dose.
- Regular review by your doctor or pharmacist (at least annually) is recommended to monitor your treatment and adjust as needed.
In Australia, lifestyle considerations such as sun exposure (relevant for transdermal patches) and varied diets are taken into account for optimal therapy.
Dosing in the Morning vs Evening
- Some find taking oral doses in the evening helps with night sweats; taking in the morning may suit those who experience nausea.
- Transdermal patches are usually changed twice weekly on the same days; the timing of application is flexible but should be consistent.
- Tip: Choose a convenient time and routine—consistency helps your body and reduces the risk of missed doses.
Discuss your personal preference with your pharmacist, as your routine, sleep patterns, or symptom peaks may influence best timing.
Taking with Food or on an Empty Stomach
- Oral estradiol may be taken with or without food. Some patients find it gentler on the stomach with food.
- No special dietary restrictions apply, though a balanced diet is recommended.
- Australia’s diet, rich in calcium and vitamin D from dairy, fish, and sunlight exposure, supports bone health alongside estradiol therapy.
- Alcohol use should be minimised, as it may increase hormone side effects or interact with other medications.
Interaction Warnings
| Interaction | Details | Advice |
|---|---|---|
| Medications (e.g. rifampicin, carbamazepine, phenytoin) | Can reduce estradiol effectiveness by ↑ metabolism (enzyme inducers) | Consult your doctor; dose may need adjusting |
| Herbal supplements (e.g. St John’s Wort) | May reduce estradiol levels and effects | Avoid or discuss with your pharmacist |
| Anticoagulants (e.g. warfarin) | Oestrogens may affect blood clotting factors | Monitor INR; inform your clinic |
| Grapefruit juice | Can raise estradiol levels in blood | Best avoided during therapy |
| Alcohol | May increase liver metabolism and side effects | Limit intake, especially with oral forms |
Indications: When is Estrace Prescribed?
| Indication | Official (TGA approved) | Off-label/Additional |
|---|---|---|
| Relief of menopausal symptoms | ✓ | |
| Prevention of osteoporosis (postmenopausal women not suitable for non-hormonal therapies) | ✓ | |
| Vaginal atrophy/dryness (local therapy) | ✓ | |
| Primary ovarian insufficiency/hypogonadism | ✓ | |
| Gender-affirming hormone therapy (transgender women) | Common in Australia practice; guided by clinical protocols | |
| Menstrual cycle disorders, secondary amenorrhoea | Occasional, under specialist care |
Dosing According to Clinical Indications
| Indication | Form | Adults | Elderly | Children/Adolescents |
|---|---|---|---|---|
| Menopausal symptoms | Oral, patch, gel | 0.5–2 mg/day or patch 25–100 μg/24 hr | Use lowest dose, monitor for risk factors | Not usually indicated |
| Vaginal atrophy | Vaginal tablet/cream | 10 μg tablet or 0.5 g cream nightly for 2 weeks, then 2–3 times per week | Same as adults, but monitor closely | Not usually indicated |
| Prevention of osteoporosis* | Oral, patch | 0.5–2 mg/day or patch 25–100 μg/24 hr | Consider risks vs benefits | Not applicable |
| Hypogonadism | Oral, patch, injection | As directed by specialist | Not typical | Individually titrated by specialist |
| Gender affirmation | Oral, patch, injection | Starting at 1–2 mg/day; titrated by endocrinologist | N/A | Specialist supervision required |
*For osteoporosis, only if non-hormonal alternatives are unsuitable based on current TGA and RACGP recommendations.
Safety Profile / Side Effects
- Common: Breast tenderness, headache, nausea, irregular vaginal bleeding/spotting, bloating, leg cramps, mood changes.
- Less Common/Rare: Skin irritation (patch/gel), weight changes, libido changes.
- Serious Risks (rare, warn your doctor): Blood clots, stroke, heart attack, breast or endometrial cancer, severe allergic reaction.
| Side Effect | How Common | What To Do |
|---|---|---|
| Breast pain/tenderness | Common | Usually improves. See GP if persistent. |
| Irregular bleeding | Common | Report to GP; may need investigation. |
| Swollen legs, chest pain, breathlessness | Rare but serious | Seek urgent care—may indicate clot. |
| Severe headache, vision changes | Rare | Contact your doctor promptly. |
| Rash or skin irritation | Occasional (patch, gel forms) | Try rotating patch sites, seek advice if severe. |
Guidelines for Proper Use (Australia-specific Advice)
- Annual check-ups are recommended, including mammograms (as appropriate for your age and history) and blood pressure checks.
- Alert your GP if you have a family or personal history of blood clots, heart disease, liver disorders, breast cancer, or unexplained vaginal bleeding before starting therapy.
- If using a patch, rotate the application site (avoid breasts and waistline) and apply only to clean, dry skin.
- For vaginal tablets/creams, lie down for a few minutes after insertion to reduce leakage.
- Store medicine below 25°C; keep out of sunlight and away from children.
- If travelling within Australia, ensure you have enough supply and a copy of your prescription for border security if flying.
- Follow the latest Australian Department of Health and TGA guidelines.
Alternative Treatment Options (Australia PBS reimbursed)
- Conjugated Oestrogens (Premarin): Broadly similar effects but derived from animal sources. PBS subsidised for certain menopausal indications.
- Estriol (Ovestin): Weaker oestrogen, often preferred for local vaginal symptoms. Available in cream and tablet. PBS-listed for atrophic vaginitis.
- Non-hormonal Therapies: For those with concerns about hormone therapy, SSRIs/SNRIs (e.g., venlafaxine), gabapentin, and lifestyle measures are available. These are generally PBS-subsidised with specific indications.
- Other Oestrogen Patches (Climara, Estalis): May be suitable for those preferring a patch. PBS-listed when criteria met.
| Option | Pros | Cons |
|---|---|---|
| Estradiol (Estrace) | Bioidentical, variety of forms, well studied | Prescription only, risks similar to other oestrogens |
| Estriol (Ovestin) | Lower potency, lower systemic absorption | May not alleviate severe systemic symptoms |
| Conjugated Oestrogens (Premarin) | Long experience, alternative source | Animal-derived, less “natural” |
| Non-hormonal therapies | No hormone-related risks | Generally less effective for severe symptoms |
Legal, Registration, and Reimbursement Status in Australia
- Registered with the Therapeutic Goods Administration (TGA) under S4 (Prescription Medicine) regulation.
- Available only via doctor’s prescription; supplied via community, hospital, and online “script-in-hand” pharmacies.
- Several forms (oral, patch, vaginal, topical) are PBS-listed for eligible indications, thus subsidised for Australian residents.
- Not available over-the-counter or without a prescription in Australia.
- For hormone-related conditions not matching PBS criteria, you may pay the full private price.
Latest Research and Clinical Guidance (2022–2025)
- Recent Australian Menopause Society (AMS) and RACGP guidelines endorse oestrogen therapy as the most effective option for menopausal symptom control, recommending the lowest effective dose for the shortest possible duration (AMS 2024 Guideline).
- Large reviews confirm safety when used properly, but reinforce the need for risk assessment (especially in women with a history of VTE, cancer, or cardiovascular disease).
- Transdermal oestrogen shows a lower risk of blood clots compared to oral forms—gaining preference where appropriate (Stuenkel CA et al, JAMA 2022; Baber RJ et al, Climacteric 2023).
- Ongoing research into oestrogen’s neurological and metabolic effects continues, with some studies suggesting potential benefits for cognitive function and cardiovascular system, though this is still under investigation (The Lancet, 2025 review).
Availability and Delivery
| Pack Size / Form | Typical Price Range (AUD) | Prescription Required? |
|---|---|---|
| Estrace 1 mg x 28 tablets | $15–$25 (PBS-subsidised) / $35–$49 (private) | Yes |
| Estradiol transdermal patch x 8 (month supply) | $25–$35 (PBS) / $40–$55 (private) | Yes |
| Vaginal estradiol tablet x 24 | $20–$30 (PBS) / $35+ (private) | Yes |
| Estradiol gel 80 g (28–31 days) | $28–$38 (PBS) | Yes |
Home or pharmacy delivery times depend on your city and pharmacy service:
| City | Same-day Delivery | Next Business Day | Standard Australia Post |
|---|---|---|---|
| Sydney | Available (selected pharmacies) | Yes | 2–4 days |
| Melbourne | Available | Yes | 2–4 days |
| Brisbane | Limited | Yes | 2–4 days |
| Perth | No | Yes | 3–5 days |
| Adelaide | No | Yes | 2–5 days |
| Regional locations | No | Limited | 3–7 days |
Frequently Asked Questions (FAQ)
- Is Estrace suitable for every woman going through menopause?
Not always. Estrace is appropriate when symptoms are severe or affect quality of life and non-hormonal options are unsuitable. Your GP will evaluate your personal, family, and medical history before prescribing. - How quickly does Estrace start working?
Many patients notice symptom relief (e.g., less hot flushes) within 1–2 weeks, but full effect may take 4–6 weeks. Vaginal symptoms may improve sooner on local forms. - Is there a risk of weight gain?
Oestrogen therapy (including Estrace) can cause mild fluid retention or bloating, but significant weight gain is uncommon. A healthy diet and regular physical activity are important during therapy. - Can Estrace be used alongside other medications?
Usually, yes, but some medications and herbal supplements may interact (see interaction table above). It’s essential to inform your pharmacist or GP about all medicines, including over-the-counter and herbal remedies. - Should I stop Estrace before surgery or planned hospitalisation?
For major surgery (especially with long bedrest), your doctor may advise temporarily stopping oestrogen due to increased clot risk. Always follow your doctor’s instructions.
Important: This information is for general educational purposes. Always follow individual advice from your doctor or pharmacist. If you have any concerns or experience side effects, seek prompt professional assistance.
